The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease

European Journal of Clinical Pharmacology

Volumn 65, Issue 2, 2009, Pages 157-161

  Sun, Yan Ming ^a   Wang, Lan Feng ^a   Li, Jia ^a   Li, Zhu Qin ^a   Pan, Wei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Coronary heart disease; Genetic polymorphism; HMG CoA reductase inhibitor; Leptin receptor

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFICACY; FEMALE; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEPTOR GENE; TREATMENT DURATION;

AGED; ALLELES; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, LEPTIN; SIMVASTATIN; TREATMENT OUTCOME;

EID: 58849113457     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0578-3     Document Type: Article

References (29)

1. NK Wenger LJ Shaw V Vaccarino 2008 Coronary heart disease in women: update 2008 Clin Pharmacol Ther 83 37 51
2. PA Ades PD Savage MJ Toth DJ Schneider MC Audelin JY Bunn M Ludlow 2008 The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease Int J Obes 32 967 974
3. RS Ahima MA Lazar 2008 Adipokines and the peripheral and neural control of energy balance Mol Endocrinol 22 1023 1031
4. NC Bingham KK Anderson AL Reuter NR Stallings KL Parker 2008 Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome Endocrinology 149 2138 2148
5. S Gulturk A Cetin S Erdal 2008 Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus Saudi Med J 29 813 820
6. SM Nelson DJ Freeman N Sattar FD Johnstone RS Lindsay 2007 IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes Diabetes 56 2705 2709
7. R Baratta S Amato C Degano MG Farina G Patane R Vigneri L Frittitta 2004 Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies J Clin Endocrinol Metab 89 2665 2671
8. A Dudakovic AJ Wiemer KM Lamb LA Vonnahme SE Dietz RJ Hohl 2008 Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes J Pharmacol Exp Ther 324 1028 1036
9. G Assmann F Kannenberg DR Ramey TA Musliner SW Gutkin EP Veltri 2008 Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia Curr Med Res Opin 24 249 259
10. M Myerson C Ngai J Jones S Holleran R Ramakrishnan L Berglund HN Ginsberg 2005 Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia J Lipid Res 46 2735 2744
11. K Kajinami N Takekoshi ME Brousseau EJ Schaefer 2004 Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management Atherosclerosis 177 219 234
12. K Popko E Gorska M Wasik A Stoklosa R Plywaczewski M Winiarska D Gorecka P Sliwinski U Demkow 2007 Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients J Physiol Pharmacol 58 551 561
13. GM Van der Vleuten LA Kluijtmans A Hijmans HJ Blom AF Stalenhoef J de Graaf 2006 The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia Int J Obes 30 892 898
14. M Arca 2007 Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome Drugs 67 43 54
15. GM Keating DM Robinson 2008 Rosuvastatin: a review of its effect on atherosclerosis Am J Cardiovasc Drugs 8 127 146
16. R Tachibana-Iimori Y Tabara H Kusuhara K Kohara R Kawamoto J Nakura K Tokunaga I Kondo Y Sugiyama T Miki 2004 Effect of genetic polymorphism of OATP-C(SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors Drug Metab Pharmacokinet 19 375 380
17. NM Morton V Emilsson P de Groot AL Pallett MA Cawthorne 1999 Leptin signalling in pancreatic islets and clonal insulin-secreting cells J Mol Endocrinol 22 173 184
18. N Stefan B Vozarova A Del Parigi V Ossowski DB Thompson RL Hanson E Ravussin PA Tataranni 2002 The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism Int J Obesity Relat Metab Disord 26 1629 1632
19. KR Coenen ML Gruen AH Hasty 2007 Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice J Nutr Biochem 18 727 735
20. K Begriche P Letteron A Abbey-Toby N Vadrot MA Robin A Bado D Pessayre B Fromenty 2008 Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice Am J Physiol Endocrinol Metab 294 E939 E951
21. JL Goldstein MS Brown 1990 Regulation of the mevalonate pathway Nature 343 425 430
22. S Jiao Y Matsuzawa K Matsubara M Kubo K Tokunaga H Odaka H Ikeda T Matsuo S Tarui 1991 Abnormalities of plasma lipoproteins in a new genetically obese rat with non-insulin-dependent diabetes mellitus (Wistar fatty rat) Int J Obesity 15 487 495
23. S VanPatten N Ranginani S Shefer LB Nguyen L Rossetti DE Cohen 2001 Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance Am J Physiol Gastrointest Liver Physiol 281 G393 404
24. Y Minokoshi YB Kim OD Peroni LG Fryer C Muller D Carling BB Kahn 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415 339 343
25. N Mendez-Sanchez V Gonzalez AC King-Martinez H Sanchez M Uribe 2002 Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss J Nutr 132 2195 2198
26. ZH Wu SP Zhao HJ Ye 2006 The beneficial effects of high-density lipoprotein on adipocytes may relate to its anti-atherogenic properties Med Hypotheses 67 1195 1199
27. A Soro M Jauhiainen C Ehnholm MR Taskinen 2003 Determinants of low HDL levels in familial combined hyperlipidemia J Lipid Res 44 1536 1544
28. ND Quinton AJ Lee RJ Ross R Eastell AI Blakemore 2001 A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women Hum Genet 108 233 236
29. IJ Kullo ST Turner E Boerwinkle SL Kardia AM de Andrade 2005 A novel quantitative trait locus on chromosome 1 with pleiotropic effects on HDL-cholesterol and LDL particle size in hypertensive sibships Am J Hypertens 18 1084 1090